Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC10744 Bendamustine HCl

    盐酸苯达莫司汀; SDX-105

    A DNA alkylating agent
  3. GC11511 Vincristine sulfate

    硫酸长春新碱; Leurocristine sulfate; NSC-67574 sulfate; 22-Oxovincaleukoblastine sulfate

    An antimitotic inhibitor of tubulin polymerization

  4. GC12838 Edaravone

    依达拉奉; MCI-186

    A free radical scavenger
  5. GC15344 SP 600125

    吡唑蒽酮

    SP 600125是一种具有口服活性的、可逆的、具有选择性的ATP竞争性JNK 抑制剂,对JNK1、JNK2和JNK3的IC50分别为40、40和90nM。SP 600125常用于卵巢癌、肿瘤、帕金森病 (PD)、乳腺癌和哮喘的研究。
  6. GC17621 TPCA-1

    5-(4-氟苯基)-2-脲基噻吩-3-甲酰胺

    A selective inhibitor of IKK2
  7. GC17943 PD173074

    PD 173074,PD-173074

    PD173074是一种ATP竞争性FGFR1和VEGFR2抑制剂,IC50值分别为26nM和100-200nM,对FGFR1的选择性高于PDGFR和c-Src。
  8. GC16694 TAE684 (NVP-TAE684)

    TAE 684

    A selective ALK inhibitor
  9. GC15485 LY 294002

    LY294002/PI3K抑制剂

    LY294002是第一个合成的PI3Kα、δ和β抑制剂。

  10. GC16499 Sorafenib Tosylate

    甲苯磺酸索拉非尼; Bay 43-9006 Tosylate

    A multi-kinase inhibitor
  11. GC17198 Cycloheximide

    Naramycin A; Actidione; 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide

    环己酰亚胺是一种抗生素,它在翻译水平上抑制蛋白质合成,仅对真核细胞的细胞质(80s)核糖体起作用。
  12. GC17030 AZD6244(Selumetinib)

    司美替尼; AZD6244; ARRY-142886

    A highly selective inhibitor of MEK1/2
  13. GC13028 SB 415286

    3-[(3-氯-4-羟苯基)氨基]-4-(2-硝苯基)-1H-吡咯-2,5-二酮

    A selective inhibitor of GSK-3
  14. GC17990 PP 1

    蛋白磷酸酯酶-1(抗原),AGL 1872; EI 275

    Potent, selective Src family tyrosine kinase inhibitor
  15. GC12725 VX-765

    Belnacasan; N-(4-氨基-3-氯苯甲酰基)-3-甲基-L-缬氨酰-N-[(2R,3S)-2-乙氧基四氢-5-氧代-3-呋喃基]-L-脯氨酰胺; VX-765

    VX-765 是一种新开发的选择性小分子 caspase-1 抑制剂,可通过血脑屏障并在体外和体内减少炎症。

  16. GC10111 Regorafenib

    瑞戈非尼; BAY 73-4506

    Regorafenib是一种具口服活性的多激酶抑制剂,抑制VEGFR1/2/3,PDGFRβ,Kit,RET和Raf-1的IC50值分别为13/4.2/46,22,7,1.5和2.5nM。
  17. GC13163 Embelin

    恩贝酸; Embelic acid; Emberine; NSC 91874

    A benzoquinone with diverse biological activities
  18. GC15718 CID 2011756 An inhibitor of protein kinase D
  19. GC10816 GDC-0941

    GDC-0941

    A pan inhibitor of class I PI3K isoforms
  20. GC16893 ICG 001 ICG001 是一种靶向 Wnt/β-catenin 通路的小分子抑制剂。
  21. GC12450 BI 2536

    BI-2536;BI2536

    A potent inhibitor of Plk1
  22. GC11247 PRIMA-1MET

    APR-246

    A re-activator of the apoptotic function of mutant p53 proteins
  23. GC11065 Pifithrin-μ

    NSC 303580

    Inhibitor of p53-mediated apoptosis
  24. GC10896 Cyclic Pifithrin-α hydrobromide

    环状抑制剂-Α氢溴酸盐,Pifithrin-β

    A stable inhibitor of p53
  25. GC15503 NSC 687852 (b-AP15)

    b-AP15

    An inhibitor of the deubiquitinases USP14 and UCHL5
  26. GC12353 Mitomycin C

    丝裂霉素 C,Ametycine

    Mitomycin C是一种抗生素,从链霉菌(Streptomyces Caespitosus)或淡紫色链霉菌(Streptomyces Lavendulae)中分离出来。
  27. GC14321 Sal 003

    (2E)-3-苯基-N-[2,2,2-三氯-1-[[[(4-氯苯基)氨基]硫代甲酰基]氨基]乙基]-2-丙烯酰胺

    An inhibitor of eIF2α dephosphorylation
  28. GC12604 Fumonisin B1

    伏马菌素B1

    A mycotoxin

  29. GC12660 AZD1208

    AZD 1208;AZD-1208

    AZD1208 是一种有效、高选择性且可口服的 Pim 激酶抑制剂,对 PIM1、PIM2 和 PIM3 的 IC50 值分别为 0.4、5 和 1.9nM。
  30. GC11557 WR 1065

    硫代乙基氨基乙基胺盐酸盐

    A radioprotective agent
  31. GC13590 SJ 172550

    MDMX Inhibitor II

    A small molecule inhibitor of MDMX
  32. GC10589 RETRA hydrochloride Antitumor agent
  33. GC12086 PRIMA-1

    NSC-281668

    A re-activator of the apoptotic function of mutant p53 proteins
  34. GC12658 PhiKan 083 PhiKan 083 是一种咔唑衍生物,可与表面腔结合并稳定 Y220C(一种 p53 突变体),Kd 为 167 μM。 PhiKan 083 可用于癌症研究。
  35. GC15621 NSC 146109 hydrochloride

    XI-011

    An activator of p53
  36. GC12893 MIRA-1

    NSC 19630

    A mutant p53 reactivator
  37. GC10650 HLI 373 HLI 373 是一种有效的 Hdm2 抑制剂。
  38. GC15840 CP 31398 dihydrochloride A p53 stabilizing agent
  39. GC11496 TLQP 21 TLQP 21 是一种 VGF 衍生肽,具有内分泌和内分泌特性,是一种有效的 G 蛋白偶联受体补体 3a 受体 1 (C3aR1) 激动剂(EC50:小鼠 TLQP 21\u003d10.3 μM;人 TLQP 21\u003d68.8 μM) .
  40. GC17577 NQDI 1 A selective inhibitor of ASK1
  41. GC12393 Melphalan

    Alanine Nitrogen Mustard, Alkeran, NSC 8806, NSC 241286, L-Phenylalanine Mustard

    DNA alkylating agent

  42. GC10200 Mdivi 1

    3-(2,4-二氯-5-甲氧基苯基)-2,3-二氢-2-硫代-4(1H)-喹唑啉酮,Mitochondrial division inhibitor 1

    Mdivi-1(线粒体分裂抑制剂 1)抑制创伤性脑损伤 (TBI) 诱导的动力蛋白相关蛋白 1 (Drp1) 上调、自噬功能障碍和线粒体自噬激活。
  43. GC15865 GRI 977143

    An LPA2 receptor agonist

  44. GC17650 DAPK Substrate Peptide A DAPK1 peptide substrate
  45. GC11543 Cesium chloride

    氯化铯

    氯化铯是钾通道的阻滞剂。
  46. GC15571 SU 9516 A pro-apoptotic Cdk2/cyclin A inhibitor
  47. GC16938 Muristerone A

    米乐甾酮A

    An ecdysteroid receptor agonist
  48. GC15400 MIM1

    4-[[[2-(环己基亚氨基)-4-甲基-3(2H)-噻唑基]亚氨基]甲基]-1,2,3-苯三醇,Inhibitor of Mcl-1

    An Mcl-1 inhibiting molecule
  49. GC12046 iMAC2 iMAC2 是一种有效的 MAC 抑制剂,IC50 为 28 nM,LD50 为 15000 nM。
  50. GC15987 BIM, Biotinylated

    Bim peptide fragment with a biotin moiety attached

  51. GC16695 Bax inhibitor peptide, negative control Peptide inhibit Bax translocation to mitochondria

Items 2351 to 2400 of 2734 total

per page

Set Descending Direction